Status:
COMPLETED
The Effectiveness of Pharmacopuncture on Psychological Stress
Lead Sponsor:
Jaseng Medical Foundation
Conditions:
Psychological Stress
Eligibility:
All Genders
19-69 years
Phase:
NA
Brief Summary
This study is a double blind, randomized controlled trail. Condition/disease: Psychological Stress treatment Intervention:Pharmacopuncture
Detailed Description
"Pharmacopuncture is a treatment that combines 2 of the most frequented Korean medicine treatment methods - traditional acupuncture and herbal medicine - by injecting herbal medicine extract at acupoi...
Eligibility Criteria
Inclusion
- Patients aged 19-69 years on the date they sign the consent form.
- Patients who are suffered by Psychological Stress that occurred within 3 days after traffic accident.
- Patients who are hospitalized due to traffic accident.
- Patients with HADS-A ≥ 8 or HADS-D ≥ 8.
- Patients who provide consent to participate in the trial and return the informed consent form.
Exclusion
- Patients with progressive neurological deficit or with serious neurological symptoms.
- Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc.
- Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study.
- Patients with medical history of brain disease or surgery due to trauma.
- Patients who are addicted by drug or alcohol within the year.
- If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease.
- Patients who are pregnant or planning to become pregnant
- Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
- Patients who are difficult to complete the research participation agreement
- Other patients whose participation in the trial is judged by a researcher to be problematic
Key Trial Info
Start Date :
November 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 26 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06107777
Start Date
November 20 2023
End Date
June 26 2024
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, South Korea, 135-896